Cervel Neurotech Inc. recently made known some great news – they were able to put together $14.1 million total in funding. This particular round was participated in by two new investors, as well as existing investors – D. E. Shaw Ventures and Aberdare Ventures.
The company’s CEO, Mr. Eric Meier tells us more about this recent financing in this e-interview with Lead411:
HemaQuest Pharmaceuticals, Inc. recently gained $13 million worth of extension funding for their Series B round. This additional financing was participated in by Aberdare Ventures, Forward Ventures, and Lilly Ventures. Other existing investors like De Novo Ventures and Latterell Venture Partners also took part in this extension.
The company’s Chief Financial Officer, Tamara Seymour, recently shared a bit more about the company in this recent e-interview with Lead411: